Navigation Links
SyntheMed To Present at the AdvaMed 2008 MedTech Conference
Date:9/18/2008

ISELIN, N.J., Sept. 18 /PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion, drug delivery products and other surgical implants, announced today that it was selected to present at the AdvaMed 2008 MedTech conference being held in Washington, D.C. on September 21-24, 2008. Robert P. Hickey, President and CEO of SyntheMed, is scheduled to present on Wednesday, September 24, at 9:30 a.m. Mr. Hickey's PowerPoint presentation may be viewed at http://www.synthemed.com for thirty days after the presentation.

The purpose of the AdvaMed 2008 MedTech conference is to provide the opportunity for companies in the life sciences sector to present to an elite audience of potential investors, strategic partners and business collaborators. The selection of presenting companies is based on such criteria as: stage of product development, partnering opportunities, potential for licensing technology, intellectual property, timing of next capital raise, and overall appeal to the audience.

About AdvaMed

AdvaMed is the world's largest medical technology trade association representing over 1,600 medical technology innovators, manufacturers of medical devices, diagnostic products and medical information systems.

About SyntheMed, Inc.

SyntheMed, Inc. is a biomaterials company engaged in the development and commercialization of anti-adhesion, drug delivery products, and other surgical implants. The company is primarily focused on the advancement and expansion of product development programs based on its proprietary bioresorbable polymer technology.

Statements in this press release that are not statements of historical fact constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the company, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such risks and uncertainties include but are not limited to (i) potential adverse developments regarding the company's efforts to obtain and maintain required regulatory approvals; (ii) potential inability to secure funding as and when needed to support the company's future activities and (iii) unanticipated delays associated with manufacturing and marketing activities. Reference is made to the Company's Annual Report on Form 10-KSB for the year ended December 31, 2007 for a description of these, as well as other, risks and uncertainties.


'/>"/>
SOURCE SyntheMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. SyntheMed to Present at Canaccord Adams Small-Cap Orthopedics Conference
2. SyntheMed Files Universal Shelf Registration
3. SyntheMed to Present at the Acumen BioFin Conference
4. SyntheMed to Host Symposium on Adhesions in Cardiac Surgery
5. eResearchTechnology, Inc. to Present at the UBS Global Life Sciences Conference on September 23rd, 2008
6. Caliper Life Sciences to Present at UBS Global Life Sciences Conference
7. PharmAthene to Present Data for Protexia(R) and Valortim(R) at HHS PHEMCE Stakeholders Workshop 2008
8. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at UBS Conference
9. BioVex to Present at the UBS Global Life Sciences Conference
10. JD Technologies, LLC Selected by FCT Ingenieurkeramik GmbH to Represent Their High Performance Ceramic Expertise In the United States
11. CryoLife to Present at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... May 03, 2016 , ... Leading CEOs ... on May 31st and June 1st at The Four Seasons Hotel Boston. , ... the life sciences, offering exclusive access to key decision makers who influence deal ...
(Date:5/3/2016)... WOODLANDS, Texas , May 3, 2016  Dr. ... certified plastic surgeon in The Woodlands, Texas ... that destroys 24 percent of treated fat cells in ... and woman. Close to 90 percent of Americans report ... treatment options. Nonsurgical fat reduction procedures are a growing ...
(Date:5/2/2016)... ... 2016 , ... StarNet Communications Corp, ( http://www.starnet.com/ ) a leading publisher of ... Desktop modules to its flagship X-Win32 PC X server. The new modules enable ... user’s PC over encrypted SSH. , Traditionally, users of PC X servers deploy the ...
(Date:4/29/2016)... York , April 29, 2016 ... published by Transparency Market Research "Separation Systems for ... Share, Growth, Trends, and Forecast 2015 - 2023", ... valued at US$ 10,665.5 Mn in 2014 and ... 6.8% from 2015 to 2023 to reach US$ ...
Breaking Biology Technology:
(Date:3/21/2016)... Unique technology combines v ... security   Xura, Inc. ... digital communications services, today announced it is working alongside ... customers, particularly those in the Financial Services Sector, the ... within a mobile app, alongside, and in combination with, ...
(Date:3/14/2016)... Florida , March 14, 2016 ... the growing mobile commerce market, announces the airing of a ... channels starting the week of March 21 st .  The ... CNBC, including its popular Squawk on the Street show. ... focused on the growing mobile commerce market, announces the airing ...
(Date:3/10/2016)... 2016   Unisys Corporation (NYSE: UIS ) ... (CBP) is testing its biometric identity solution at the Otay ... to help identify certain non-U.S. citizens leaving the country. ... to help determine the efficiency and accuracy of using biometric ... will run until May 2016. --> the ...
Breaking Biology News(10 mins):